Embla Medical posts Q3 2026 net profit of USD 26 million

Bitget2026/10/20 05:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Embla Medical’s Q3 2026 net profit totaled USD 26 million, while its net profit margin fell to 10%.
Sales rose 5% year-on-year to USD 250 million, led by Prosthetics & Neuro Orthotics.
Patient Care integration efforts slowed patient-volume growth in selected regions, leaving performance below management’s expectations.
Full-year 2026 organic sales growth guidance narrowed to approximately 5% from 5–7%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Embla Medical hf. published the original content used to generate this news brief via Cision (Ref. ID: 20261019:BIT:6567:0) on October 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Embla Medical posts Q3 2026 net profit of USD 26 million

You may also like

Crypto prices